Non-invasive synchronous bladder, uroflowmetry and heart rate and heart rate variability for outpatient clinical use in lower urinary tract symptoms and cardiovascular disease
Recent scientific studies have supported the importance of measurement of heart rate (HR) and heart rate variability (HRV) related to cardiovascular disease (CVD). CVD is a known risk factor for both lower urinary tract symptoms (LUTS) and overactive bladder (OAB). There is currently no outpatient test to measure HR and HRV to uroflowmetry and detrusor oxygenation during voiding. Objective: To test in an outpatient clinic setting a synchronous, noninvasive measurement of HR and HRV, detrusor activity, and uroflowmetry using optical systems. This study confirm the feasability of this new methodology which can now be used for larger scale clinical diagnostic studies in LUTS.
Authors
- Lynn Stothers (ORCID: https://orcid.org/0000-0001-7841-1748)
- Kyle B. Zuniga (ORCID: https://orcid.org/0000-0003-3759-3658)
- Andrew Macnab (ORCID: https://orcid.org/0000-0002-8583-2986)
Institutions
- University of British Columbia (CA)
- University of California, Los Angeles (US)
Publication Details
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1117/12.3047427
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00